Archives
-
Tacrolimus (FK506) at the Metabolism–Immunity Interface
2026-09-25
Tacrolimus (FK506) is a potent calcineurin inhibitor for studying immune signaling, but metabolic stress can independently reshape cellular defenses. This article connects those ideas to the AMPK–SQSTM1/p62 feedback loop and explains how to design experiments that distinguish the pathways without overstating what the evidence proves.
-
Dextromethorphan Hydrobromide: Interpreting Neuroprotection
2026-09-24
Dextromethorphan hydrobromide can help probe excitotoxicity, but interpreting protection requires separating ion-channel effects from downstream cell outcomes. This article offers an assay-attribution framework and a carefully qualified comparison with a PDK4 inhibitor study.
-
Separating Vascular Reactivity from Hypertension
2026-09-24
Sodium Nitroprusside offers translational researchers a controllable way to probe nitric oxide–responsive vascular relaxation. Paired with sex-stratified angiotensin II models, it can help distinguish vascular responsiveness from the broader autonomic and hormonal influences shaping blood pressure.
-
Sodium Nitroprusside in Vascular Research
2026-09-23
Use Sodium Nitroprusside as a controlled nitric oxide donor to test vascular smooth muscle responsiveness separately from the hormonal and neural influences that shape hypertension in vivo. This practical guide connects sex-specific angiotensin II findings to vessel-ring and platelet workflows, with titration-based starting conditions and troubleshooting advice.
-
CDELNs Relieve Sertoli Cell Cycle Arrest
2026-09-23
This version 1 preprint reports that Cistanche deserticola exosome-like nanovesicles preferentially enter Sertoli cells and alleviate cyclophosphamide-associated testicular injury. The proposed mechanism links heparan sulfate proteoglycan-mediated uptake to delivery of miR159b-3p, suppression of P21, and restoration of CDK1 activity, with human single-cell transcriptomic data providing translational context.
-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-09-22
This study used an activity-based screen of approximately 6,000 compounds to identify merbromin as a selective inhibitor of the SARS-CoV-2 3CLpro/Mpro protease. Kinetic, binding, and docking analyses supported a mixed-type mechanism involving two putative binding sites, providing a biochemical scaffold for antiviral inhibitor development while leaving cellular efficacy and safety unresolved.
-
Fluorescein Tyramide: From Signal to Circuit Insight
2026-09-22
A thought-leadership analysis of how Fluorescein Tyramide can connect ultrasensitive tissue labeling with mechanistic neuroscience, using new evidence on early life adversity, oxytocin signaling, and visually evoked defensive behavior to guide translational assay design.
-
Caffeine as a Mechanistic Assay Tool
2026-09-21
Caffeine research is strongest when receptor pharmacology, concentration, model context, and orthogonal readouts are interpreted together. This guide develops a decision framework for using 1,3,7-trimethylpurine-2,6-dione in cancer, metabolic, and translational assays without overextending model-specific findings.
-
Thrombin B-Chain Fragment: A Translational Lens
2026-09-21
Thrombin is more than a clot-forming enzyme: it is a context-dependent signaling hub linking fibrin formation, platelet biology, inflammation, and vascular pathology. This thought-leadership article explains how the Coagulation Factor II (Thrombin) B Chain Fragment can support sequence-defined, analytically rigorous workflows while clarifying why a peptide fragment should not be treated as a substitute for catalytically active full-length thrombin.
-
Eicosapentaenoic Acid (EPA) Assay Guide
2026-09-20
This scenario-based guide explains how Eicosapentaenoic Acid (EPA), SKU B3464, can improve the design and interpretation of cell viability, migration, and lipid oxidation experiments. It connects concentration selection, solvent controls, assay compatibility, literature boundaries, and reagent-quality decisions for more reproducible cardiovascular disease research.
-
(S)-(+)-Dimethindene maleate: M2 Assay Guide
2026-09-19
This guide explains how to handle (S)-(+)-Dimethindene maleate as a research reagent for M2 muscarinic receptor and H1 histamine receptor antagonist studies. It supports receptor profiling and functional assay setup, but it should not be used to infer clinical effects, therapeutic dosing, or long-term solution stability.
-
Heparin sodium Workflows for Coagulation Research
2026-09-18
Build reproducible anti-factor Xa and aPTT workflows with Heparin sodium while preserving the interpretability of plasma, animal, and nanovesicle experiments. This guide connects anticoagulation controls with a recent Sertoli-cell nanovesicle study and highlights where heparin is useful—and where it can become a mechanistic confounder.
-
1-myristoylglycerophosphocholine: Applied Workflows
2026-09-18
Use 1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, as a defined lysophospholipid input for smooth muscle assays and epithelial–fibroblast fibrosis models. This guide connects practical dosing, preparation, controls, and troubleshooting to the HMGCS2–Lyso-PC mechanism reported in pulmonary fibrosis research.
-
Isorhamnetin in Oocyte Stress Research
2026-09-17
Isorhamnetin provides a mechanism-oriented way to connect oocyte maturation with oxidative stress, apoptosis, endoplasmic reticulum stress, and PI3K/Akt signaling. This guide translates the published 10 µM, 44-hour porcine oocyte experiment into practical assay workflows, controls, and troubleshooting strategies.
-
Central Control of Opioid Hypersensitivity in Mice
2026-09-17
Yin et al. identify a brain-to-spinal opioid circuit that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Their findings show that MOR activation can paradoxically disrupt spinal control of mechanically evoked pain, providing a circuit-level framework for interpreting opioid-induced pain sensitization and for designing targeted opioid receptor signaling research.